Drug Development, Testing and Marketing

Please use the attached articles and link to answer Q1&Q2 and
as your References

Question-1(minimum of 4 paragraph answer on the first page)
Is there bias in drug development and clinical
research of new drugs? Comment on some factors that can minimize bias in drug
testing. Who should be responsible for regulating drug testing?

Question-2 (minimum of
4 paragraph answer on the second page)
How is the “off-label” use of
medications beneficial to patients and what are the risks of this practice?
What are some of the ethical considerations and regulations related to the
off-label use of drugs? How did the COVID-19 outbreak transform the use of
“off-label” drugs? Start with the links below.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207985/
https://www.medicaleconomics.com/view/label-prescribing-era-covid-19

Last Completed Projects